Switch to
More onapp

How to use scorecard? Learn more

Auro Laboratories Ltd

AUROLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹174 cr, stock is ranked 2,645
High RiskStock is 3.63x as volatile as Nifty
280.000.90 (-0.32%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Bad

The stock is overpriced and in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹174 cr, stock is ranked 2,645
High RiskStock is 3.63x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
28.29
PB RatioPB Ratio
4.16
Dividend YieldDiv. Yield
Sector PESector PE
51.92
Sector PBSector PB
6.65
Sector Div YldSctr Div Yld
0.51%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Auro Laboratories Limited is engaged in the business of bulk drugs. It manufactures active pharmaceutical ingredients (APIs), intermediates and generic formulations.

Financial TrendFinancial statements 

202120222023202455.0151.9653.8355.147.182.842.457.79
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnDec 16, 2024

AURO LABORATORIES LTD. - 530233 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | Download

AURO LABORATORIES LTD. - 530233 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | Download

Company Update 
Announced OnNov 13, 2024

AURO LABORATORIES LTD. - 530233 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Download

AURO LABORATORIES LTD. - 530233 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Download

Result 
Announced OnNov 11, 2024

AURO LABORATORIES LTD. - 530233 - Financial Results For The Quarter And Half Year Ended September 30, 2024 | Download

AURO LABORATORIES LTD. - 530233 - Financial Results For The Quarter And Half Year Ended September 30, 2024 | Download

See all events